NCT00282594View on ClinicalTrials.gov

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

NACompletedINTERVENTIONAL
Enrollment

317

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

October 31, 2005

Conditions
SepsisRespiratory FailureRenal FailureSurgical Site Infection
Interventions
DRUG

Novolin R (human recombinant Insulin)

Trial Locations (1)

48439

Genesys Regional Medical Center, Grand Blanc

Sponsors

Lead Sponsor

Genesys

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Genesys

OTHER